Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate.
Uz B, Buyukasik Y, Atay H, Kelkitli E, Turgut M, Bektas O, Eliacik E, Isik A, Aksu S, Goker H, Sayinalp N, Ozcebe OI, Haznedaroglu IC. Uz B, et al. Among authors: eliacik e. Hematology. 2013 Sep;18(5):247-52. doi: 10.1179/1607845412Y.0000000071. Epub 2013 Mar 20. Hematology. 2013. PMID: 23540886 Free article.
Long-term sustained hemorrhage due to bone marrow biopsy successfully treated with topical ankaferd hemostat in a bleeding-prone patient with secondary amyloidosis.
Uz B, Guven GS, Isik A, Kuyumcu ME, Bektas O, Eliacik E, Aksu S, Goker H, Buyukasik Y, Sayinalp N, Haznedaroglu IC. Uz B, et al. Among authors: eliacik e. Clin Appl Thromb Hemost. 2013 Jun;19(3):338-40. doi: 10.1177/1076029612457709. Epub 2012 Aug 21. Clin Appl Thromb Hemost. 2013. PMID: 22914810 Free article. No abstract available.
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H, Ozdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Karacan Y, Unal S, Eliacik E, Isik A, Ozcebe OI. Goker H, et al. Among authors: eliacik e. Transfus Apher Sci. 2013 Dec;49(3):590-9. doi: 10.1016/j.transci.2013.07.030. Epub 2013 Aug 8. Transfus Apher Sci. 2013. PMID: 23981652
Rebound Thrombocytosis following Induction Chemotherapy is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission.
Malkan UY, Gunes G, Isik A, Eliacik E, Etgul S, Aslan T, Balaban MS, Haznedaroglu IC, Demiroglu H, Goker H, Ozcebe OI, Sayınalp N, Aksu S, Buyukasik Y. Malkan UY, et al. Among authors: eliacik e. Acta Haematol. 2015;134(1):32-7. doi: 10.1159/000369917. Epub 2015 Apr 8. Acta Haematol. 2015. PMID: 25872012 Free article. Clinical Trial.
High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.
Bektas O, Uner A, Aydin SM, Eliacik E, Uz B, Işık A, Haznedaroğlu IC, Goker H, Sayinalp N, Aksu S, Demiroglu H, Ozcebe OI, Buyukasik Y. Bektas O, et al. Among authors: eliacik e. Int J Hematol. 2015 Aug;102(2):211-7. doi: 10.1007/s12185-015-1816-y. Epub 2015 May 26. Int J Hematol. 2015. PMID: 26009282
23 results